Building upon this, Zuo et al. developed a genetically engineered fusion protein by linking the damage‐associated molecular pattern (DAMP) molecule HMGN1 to the EV‐anchoring peptide CP05.[241] TEXs secreted from Hepa1–6 hepatocellular carcinoma cells, bearing HMGN1 (TEX‐N1ND), were pulsed onto DCs to generate the DC‐TEX‐N1ND vaccine. The gene discussed is HMGN1; the disease is hepatocellular carcinoma.